West Pharmaceutical Services, Inc. Stock Mexican S.E.
Stocks
WST *
US9553061055
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
2025-12-04
|
5-day change | 1st Jan Change | ||
| 5,112.51 MXN | +15.28% |
|
-.--% | - |
| 08-03 | Is everything under control? |  |
| 07-31 | Amgen discloses data breach involving patient health information | RE |
| Market Cap | 24.87B 422B 21.31B 19.94B 18.23B 34.39B 2,381B 34.76B 236B 91.73B 1,196B 93.36B 91.34B 3,956B | P/E 2026 * |
41.2x | P/E 2027 * | 35.8x |
|---|---|---|---|---|---|
| Enterprise Value | 24.36B 413B 20.88B 19.53B 17.86B 33.7B 2,333B 34.06B 231B 89.87B 1,171B 91.47B 89.49B 3,876B | EV / Sales 2026 * |
7.22x | EV / Sales 2027 * | 6.64x |
| Free-Float |
92.89% | Yield 2026 * |
0.26% | Yield 2027 * | 0.28% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | +15.28% |
| 1 year | 4,435 |  | 5,112.51 |
| 3 years | 4,000 | | 7,104.95 |
| 5 years | 4,000 | | 9,649 |
| 10 years | 4,000 | | 9,649 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +15.28% | -.--% | - | - | 24.85B | |
| +0.03% | +5.71% | -12.01% | +12.45% | 202B | |
| -0.48% | +2.54% | +0.20% | +14.61% | 119B | |
| +1.80% | +3.60% | +10.65% | +81.11% | 60.69B | |
| -1.23% | -6.56% | +27.44% | +56.46% | 52.38B | |
| -0.66% | +4.75% | -4.47% | -31.14% | 52.3B | |
| -1.39% | +2.59% | +10.70% | -9.82% | 34.85B | |
| +1.28% | -0.52% | - | - | 30.06B | |
| +0.07% | +1.94% | +42.55% | -9.80% | 24.85B | |
| +0.12% | +0.89% | -1.03% | +25.11% | 23.84B | |
| Average | +1.48% | +1.03% | +9.26% | +17.37% | 66.7B | |
| Weighted average by Cap. | +0.53% | +2.64% | +1.50% | +18.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 57.22B 2.89B 2.71B 2.47B 4.67B 323B 4.72B 32.01B 12.45B 162B 12.67B 12.4B 537B | 3.59B 60.82B 3.07B 2.88B 2.63B 4.96B 343B 5.01B 34.03B 13.23B 172B 13.47B 13.18B 571B |
| Net income | 615M 10.42B 527M 493M 450M 850M 58.84B 859M 5.83B 2.27B 29.55B 2.31B 2.26B 97.76B | 701M 11.89B 601M 562M 514M 970M 67.14B 980M 6.65B 2.59B 33.72B 2.63B 2.58B 112B |
| Net Debt | -503M -8.53B -431M -403M -369M -696M -48.19B -704M -4.77B -1.86B -24.2B -1.89B -1.85B -80.06B | -1.04B -17.62B -891M -833M -762M -1.44B -99.5B -1.45B -9.86B -3.83B -49.96B -3.9B -3.82B -165B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
- WST * Stock
Select your edition
All financial news and data tailored to specific country editions
